Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-04-30

Development of ultrasensitive assays for detection of viral agents, genetic disorders in clinical samples including gene therapy

Objectif



The aim of this project is the further development of a quantitative polymerase chain reaction 4 system for different diagnostic applications and the evaluation of large scale applicability in ind screening. Diagnostic kits for viruses, genome instabilities, genomic dysmorphologies, specifi receptors and gene therapy shall be developed. A reverse transcriptase assay for retrovirus det and quantification (= reference system) will be the basis for the development of this novel quan PCR system. A number of various research areas can be covered: biomedical technology, engineering, comparative human genome analyses and diseases with major socio economic impe cancer. AIDS, brain disorders or other rare diseases.

Thème(s)

Data not available

Appel à propositions

Data not available

Régime de financement

EAW - Exploratory awards

Coordinateur

R + S Biotec GmbH
Contribution de l’UE
Aucune donnée
Adresse
28A,Wielandstrasse
32545 Bad Oeynhausen
Allemagne

Voir sur la carte

Coût total
Aucune donnée

Participants (2)